Total amount raised
$322.6 Million
Latest funding date
07/01/2024
Location
Huma has successfully raised funding over 11 rounds, with the latest being a Series D round. The company is backed by 16 investors, including HAT Sicaf and Leaps by Bayer.
Keep reading to explore the intricacies of Huma's fundraising journey and the investors backing this innovative health platform.
What Is Huma?
Huma, based in London, England, is a pioneering company in the fields of Artificial Intelligence, Health Care, mHealth, and SaaS. The company offers a health platform designed for remote patient monitoring and biological data gathering, aiming to enhance preventative healthcare.
Founded with a mission to optimize patient health through digital and AI-driven products, Huma has grown to employ between 101-250 people. The company has supported nearly 100 million people worldwide and is committed to regulatory compliance and data security across multiple continents.
How Much Funding Has Huma Raised?
- Seed Round
- Amount Raised: USD 1,000,000
- Date: January 2016
- Lead Investors: Not publicly disclosed
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To kickstart the development of Huma's health platform and support initial operations.
- Series A Round
- Amount Raised: USD 28,000,000
- Date: February 2018
- Lead Investors: NWS Holdings
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To expand the platform's capabilities and scale operations.
- Series A Round
- Amount Raised: Not publicly disclosed
- Date: April 2019
- Lead Investors: Not publicly disclosed
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To further enhance the platform and support growth initiatives.
- Series B Round
- Amount Raised: USD 50,000,000
- Date: November 2019
- Lead Investors: Leaps by Bayer
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To accelerate the development of AI-driven health solutions and expand market reach.
- Series C Round
- Amount Raised: USD 100,000,000
- Date: May 2021
- Lead Investors: Hitachi Ventures, Leaps by Bayer
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To scale the platform globally and invest in new AI technologies.
- Debt Financing
- Amount Raised: USD 30,000,000
- Date: May 2021
- Lead Investors: Not publicly disclosed
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To support operational expenses and strategic initiatives.
- Non-Equity Assistance
- Amount Raised: Not publicly disclosed
- Date: September 2021
- Lead Investors: Future Fifty
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To gain strategic support and resources for scaling the business.
- Corporate Round
- Amount Raised: GBP 25,000,000
- Date: March 2022
- Lead Investors: AstraZeneca
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To strengthen partnerships and enhance the platform's capabilities.
- Grant
- Amount Raised: GBP 493,877
- Date: January 2023
- Lead Investors: SBRI Healthcare
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To fund specific health projects and innovations.
- Series D Round
- Amount Raised: USD 80,000,000
- Date: July 2024
- Lead Investors: Not publicly disclosed
- Valuation at Round: Near USD 1 billion
- Motivation Behind the Round: To develop the Huma Cloud Platform and expand AI capabilities.
Total Amount Raised: USD 290,000,000
Current Valuation: Near USD 1 billion
Key Investors
- AstraZeneca
- Details: AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines. It is headquartered in Cambridge, UK, and operates in over 100 countries.
- Investment Focus Areas: Pharmaceuticals, biotechnology, healthcare.
- Notable Investments: Various biotech startups, healthcare technology companies.
- Leaps by Bayer
- Details: Leaps by Bayer is the investment arm of Bayer, focusing on breakthrough innovations in health and agriculture. It aims to address some of the world's biggest challenges through transformative technologies.
- Investment Focus Areas: Life sciences, health technologies, innovative healthcare solutions.
- Notable Investments: Biotech startups, health tech startups.
- Hat Technology Fund 4 by HAT SGR
- Details: Hat Technology Fund 4 by HAT SGR is a venture capital fund managed by HAT SGR, focusing on investments in technology and innovation. The fund supports companies that drive digital transformation.
- Investment Focus Areas: Technology, innovation, digital transformation.
- Notable Investments: Tech startups, companies focusing on digital transformation.
- HV Fund by Hitachi Ventures
- Details: HV Fund by Hitachi Ventures is the corporate venture capital arm of Hitachi, investing in innovative startups and technologies. It aims to foster growth in sectors that align with Hitachi's strategic interests.
- Investment Focus Areas: Technology, innovation, industrial solutions.
- Notable Investments: Tech startups, companies focusing on industrial and technological innovations.
- HAT Sicaf
- Details: HAT Sicaf is an investment firm that provides financial backing to innovative companies. It focuses on supporting growth and development in various sectors.
- Investment Focus Areas: Not specified.
- Notable Investments: Not specified.
What's Next for Huma?
Huma's future looks promising as it leverages its recent $80 million Series D funding to expand its AI-driven healthcare platform. The Huma Cloud Platform, already in use in over 3,000 hospitals and clinics, offers significant growth potential by enabling rapid development and deployment of digital health solutions. This expansion is bolstered by partnerships with tech giants like Google and major pharmaceutical companies, positioning Huma to lead in the digital health space.
With the healthcare industry increasingly adopting AI and digital solutions, Huma is well-placed to attract further investment. The company's near-$1 billion valuation and successful track record make it an attractive prospect for future funding rounds. However, Huma will need to navigate regulatory challenges and ensure data security to maintain its competitive edge.
Use Clay to Get Funding Data
Sales professionals, leverage Clay’s platform to access comprehensive fundraising data on companies like Huma and gather other critical business insights.
Sign up for free to start transforming your sales strategy today.
